Fatty liver disease: With little early detection, more challenging drug development
pharmaphorum
AUGUST 25, 2022
That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. That is a moral failure on the part of medicine. Dozens of companies are working at various stages of drug development.
Let's personalize your content